U

Ultimovacs ASA
OSE:ULTI

Watchlist Manager
Ultimovacs ASA
OSE:ULTI
Watchlist
Price: 14.5 NOK 0.69% Market Closed
Market Cap: 293.3m NOK

Net Margin
Ultimovacs ASA

0%
Current
0%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-201.1m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Ultimovacs ASA
Glance View

Market Cap
293.3m NOK
Industry
Biotechnology

Ultimovacs AS operates as a pharmaceutical company. The company is headquartered in Oslo, Oslo. The company went IPO on 2019-06-03. The firm's lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase. UV1 is being developed as a therapeutic cancer vaccine which may serve as a platform for use in combination with other immuno-oncology drugs which require an ongoing T cell response for their mode of action. The firm is performing a broad clinical development program with clinical trials in Europe and the USA.

ULTI Intrinsic Value
Not Available
U
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-201.1m
/
Revenue
0
What is the Net Margin of Ultimovacs ASA?

Based on Ultimovacs ASA's most recent financial statements, the company has Net Margin of 0%.

Back to Top